Breast cancer: Latest News, Top Stories & Analysis

ENHERTU plus Pertuzumab Shows Significant Progress in First-Line Treatment for HER2-Positive Breast Cancer

June 8, 2025June 7, 2025 - by Timothy Alexander

WILMINGTON, DE — The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab significantly improves progression-free survival (PFS) for patients with HER2-positive metastatic …

Cancer / Regional

AstraZeneca’s SERENA-6 Trial Marks Breakthrough in Breast Cancer Treatment

June 3, 2025June 1, 2025 - by Timothy Alexander

WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced breast cancer. The trial demonstrated …

Regional

Farmers of Salem Celebrates Loraine Lester’s Contributions to Community and Career

May 17, 2025May 16, 2025 - by Timothy Alexander

WILMINGTON, DE — Farmers of Salem, a regional mutual insurance company specializing in coverage for homes and businesses, is celebrating Loraine Lester, AVP of Product & Underwriting Development, for her …

Regional

ENHERTU Shows Promise in Early-Stage HER2-Positive Breast Cancer

May 14, 2025May 13, 2025 - by Timothy Alexander

WILMINGTON, DE — Positive results from the DESTINY-Breast11 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), when followed by paclitaxel, trastuzumab, and pertuzumab (THP), significantly improved pathologic complete response (pCR) …

Regional

ENHERTU Combination Shows Promising Results in HER2-Positive Metastatic Breast Cancer Trial

April 28, 2025April 27, 2025 - by Timothy Alexander

WILMINGTON, DE — High-level results from the DESTINY-Breast09 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), in combination with pertuzumab, significantly improves progression-free survival (PFS) compared to the current 1st-line …

Cancer

Tower Health Launches “Slam Dunk Mammo Screening” Campaign

March 13, 2025March 13, 2025 - by Timothy Alexander

WEST READING, PA — Tower Health is urging women to prioritize their breast health this March through its “Slam Dunk Mammo Screening” campaign. The initiative, running throughout the month, encourages women …

Mergers and Acquisitions

Galera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer Treatment

January 2, 2025December 31, 2024 - by Timothy Alexander

MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) has announced its acquisition of Nova Pharmaceuticals, Inc., a biotechnology company focused on treating resistant forms of breast cancer, including metaplastic and …

Cancer

Medicaid Expansion Linked to Improved Breast Cancer Outcomes

October 29, 2024October 28, 2024 - by Timothy Alexander

PLYMOUTH MEETING, PA — New research unveiled in the Journal of the National Comprehensive Cancer Network (JNCCN) highlights significant benefits of Medicaid expansion under the Affordable Care Act for patients …

Pennsylvania

Pennsylvania Insurance Department Honored for Pioneering Breast Cancer Screening Law

October 28, 2024October 28, 2024 - by Maryann Pugh

HARRISBURG, PA — The Pennsylvania Insurance Department (PID) has been recognized for its pivotal role in enhancing breast cancer screening access, earning Insurance Commissioner Michael Humphreys the prestigious Pink Ribbon …

Philadelphia's Fashion District Hosts Breast Cancer Awareness Event

Regional

Join Your Community at Paint the Mall Pink: Unite for Breast Cancer Awareness!

October 9, 2024October 9, 2024 - by Alec Robson

PHILADELPHIA, PA — Fashion District Philadelphia, renowned for its vibrant community engagement, is set to host “Paint the Mall Pink” on Saturday, October 12th. This event, orchestrated in collaboration with Philly …